Journal supplement outlines updated guidelines, reporting standards

Feb 01, 2021 Re-posted from the February 2021 issue of Vascular Specialist

By Beth Bales

The Society for Vascular Surgery (SVS) is starting 2021 with updated guidelines and reporting standards for three vascular conditions.

Guidelines on chronic mesenteric ischemia have been developed to provide the best possible evidence for the diagnosis and treatment of patients with chronic mesenteric ischemia (CMI) from atherosclerosis, the guidelines focus on six specific areas, including the diagnostic evaluation, indications for treatment, choice of treatment, perioperative evaluation, endovascular/ open revascularization and surveillance/ remediation. In addition to highlighting areas for further research, these guidelines are intended to help guide the optimal care of patients with CMI.

In the guidelines on thoracic endovascular aortic repair (TEVAR) for descending thoracic aortic aneurysms, the authors provide 36 important recommendations on the use of TEVAR for descending thoracic aortic aneurysm (TAA). The reporting standards for endovascular aortic repair of aneurysms involving the renal-mesenteric arteries clarify and update terminology, classification systems, measurement techniques and end-point definitions.

All are outlined and reported in a supplement to the January issue of the Journal of Vascular Surgery. Visit vsweb. org/Jan21Supplement

Tags
Vascular Specialist

Related Articles

Education and Representation at the Core of Inclusivity Efforts for DEI Committe

This article was published in the October issue of Vascular Specialist.

The Society for Vascular Surgery’s (SVS) Diversity, Equity, and Inclusion (DEI) Committee continues to make strides in advancing inclusivity within the organization, with several projects underway to address both ongoing challenges and new opportunities.

Why donate to the SVS PAC?

A few years ago, in his presidential address to the Midwestern Vascular Surgical Society, Mark Mattos, MD, spoke eloquently about the need to “protect our specialty.” A large part of this, he argued, is protecting our patients; no other specialty in medicine can provide the type of comprehensive vascular care that we offer. The daily reality we all face is the potential for declining Medicare reimbursement for our services.

Progress made during year like no other

While the COVID-19 pandemic and its effects dominated 2020–21 fiscal year—including the cancellation of the live 2020 Vascular Annual Meeting (VAM)—it did not deter progress on many important initiatives. “When covid hit, it intensified our focus on what was truly important: our members, their patients and the SVS as their Society,” said Executive Director Kenneth M. Slaw, PhD. “That focus was sustained the past 15 months and it has led to innovation and an unprecedented volume of member value programs.” He outlined important highlights from the fiscal year that ended March 31—just more than a year after the pandemic was declared—and the vital initiatives that continue to move forward.